Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
38.52
40.90
50.22
52.28
49.05
42.18
46.90
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
38.52
40.90
50.22
52.28
49.05
42.18
46.90
Raw Material Cost
18.64
18.82
25.88
26.50
24.78
23.14
23.58
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
7.80
5.53
5.35
4.83
4.84
4.84
5.19
Other Expenses
0.07
0.08
0.06
0.05
0.05
0.05
0.05
Total Expenditure (Excl Depreciation)
27.12
25.17
31.79
31.82
30.15
28.47
29.26
Operating Profit (PBDIT) excl Other Income
11.399999999999999
15.700000000000001
18.400000000000002
20.5
18.9
13.700000000000001
17.6
Other Income
2.71
3.21
3.31
0.87
0.18
0.13
0.25
Operating Profit (PBDIT)
17.06
21.79
28.12
28.41
26.37
21.05
24.78
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Items
0.00
-2.14
-1.66
-0.67
-0.02
0.00
-0.02
Gross Profit (PBDT)
19.88
22.08
24.35
25.78
24.27
19.03
23.32
Depreciation
2.95
2.85
6.37
7.08
7.28
7.21
6.88
Profit Before Tax
14.11
16.80
20.09
20.66
19.06
13.84
17.88
Tax
2.82
2.93
3.45
4.19
4.27
3.04
3.16
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
11.29
13.87
16.64
16.47
14.79
10.80
14.73
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
11.29
13.87
16.64
16.47
14.79
10.80
14.73
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
11.29
13.87
16.64
16.47
14.79
10.80
14.73
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
119.27
117.43
128.31
114.25
107.14
102.82
101.09
Earnings per share (EPS)
3.48
3.96
4.57
4.52
4.04
2.94
3.94
Diluted Earnings per share
3.48
3.96
4.57
4.52
4.04
2.94
3.94
Operating Profit Margin (Excl OI)
29.6%
38.46%
36.71%
39.13%
38.53%
32.5%
37.63%
Gross Profit Margin
44.29%
48.04%
52.68%
53.06%
53.71%
49.91%
52.8%
PAT Margin
29.3%
33.92%
33.12%
31.51%
30.15%
25.6%
31.4%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is -5.87% vs -18.53% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is -18.71% vs -16.27% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is -22.58% vs -25.00% in Dec 2024
Interest
No Interest in the last few periods
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
Compare Annual Results Of Utah Medical Products, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
38.52
329.52
-291.00
-88.31%
Other Operating Income
0.00
0.00
0.00
Total Operating income
38.52
329.52
-291.00
-88.31%
Raw Material Cost
18.64
81.82
-63.18
-77.22%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
1.04
-1.04
-100.00%
Selling and Distribution Expenses
7.80
209.94
-202.14
-96.28%
Other Expenses
0.07
0.74
-0.67
-90.54%
Total Expenditure (Excl Depreciation)
27.12
300.24
-273.12
-90.97%
Operating Profit (PBDIT) excl Other Income
11.40
29.28
-17.88
-61.07%
Other Income
2.71
3.10
-0.39
-12.58%
Operating Profit (PBDIT)
17.06
39.02
-21.96
-56.28%
Interest
0.00
1.04
-1.04
-100.00%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
19.88
247.70
-227.82
-91.97%
Depreciation
2.95
6.64
-3.69
-55.57%
Profit Before Tax
14.11
31.34
-17.23
-54.98%
Tax
2.82
12.25
-9.43
-76.98%
Provisions and contingencies
0
0
0.00
Profit After Tax
11.29
19.09
-7.80
-40.86%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
11.29
19.09
-7.80
-40.86%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
11.29
19.09
-7.80
-40.86%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
119.27
218.90
-99.63
-45.51%
Earnings per share (EPS)
3.48
0.82
2.66
324.39%
Diluted Earnings per share
3.48
0.82
2.66
324.39%
Operating Profit Margin (Excl OI)
29.60%
8.89%
0.00
20.71%
Gross Profit Margin
44.29%
11.53%
0.00
32.76%
PAT Margin
29.30%
5.79%
0.00
23.51%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 3.85 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -5.87% vs -18.53% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 1.13 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -18.71% vs -16.27% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1.44 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -22.58% vs -25.00% in Dec 2024
Annual - Interest
No Interest in the last few periods
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 29.60%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has fallen from Dec 2024






